Eculizumab (Soliris)

eculizumab · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eculizumab (Soliris), covering 2019-03-21 to 2019-03-21. Get the full timeline:

Most recent: Clinical Trial Update: ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab [Phase 3]

See pricing